Ceftzim-T 281.25

Description

Ceftzim-T 281.25 is a sterile injectable formulation containing Ceftazidime 250mg and Tazobactam 31.25mg, a broad-spectrum cephalosporin antibiotic combined with a beta-lactamase inhibitor. The formulation is designed to provide enhanced antibacterial activity against susceptible bacterial infections and is intended for use under the supervision of healthcare professionals. Cetzim-T 281.25 supports effective infection management in hospital and clinical settings.

Composition

Ceftazidime 250mg + Tazobactam 31.25mg

Pack Size

Vial with WFI

Packing

With Carton

Therapeutic Segment

Injectable Antibiotic | Anti-Infective Therapy | Bacterial Infection Management

Key Benefits

Provides broad-spectrum antibacterial support
Helps manage susceptible bacterial infections
Enhances antibiotic effectiveness through beta-lactamase inhibition
Supports effective treatment of bacterial infections
Sterile injectable formulation
Suitable for hospital and clinical use
To be administered under the supervision of a healthcare professional

Packaging

Vial with WFI and Carton